IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 2 filers reported holding IBERE PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,467 | -78.7% | 250,974 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $21,000 | +23.5% | 250,974 | +15.0% | 0.00% | 0.0% |
| Q2 2022 | $17,000 | -32.0% | 218,283 | +73.2% | 0.00% | 0.0% |
| Q1 2022 | $25,000 | -47.9% | 126,050 | +43.0% | 0.00% | -50.0% |
| Q4 2021 | $48,000 | +45.5% | 88,163 | +60.1% | 0.00% | +100.0% |
| Q3 2021 | $33,000 | – | 55,072 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |